FORM 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

May 10, 2012

Date of Report (Date of earliest event reported)

 

 

Medicis Pharmaceutical Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-14471   52-1574808

(State or other jurisdictions

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

7720 North Dobson Road

Scottsdale, Arizona 85256

(Address of principal executive offices) (Zip Code)

(602) 808-8800

(Registrant’s telephone number, including area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

TABLE OF CONTENTS

 

Item 8.01 Other Events

Item 9.01 Financial Statements and Exhibits.

SIGNATURES

EX-99.1

Item 8.01 Other Events.

Medicis Pharmaceutical Corporation (the “Company”) is furnishing the unaudited pro forma condensed combined statement of operations of the Company and Graceway Pharma Holding Corp. and subsidiaries for the year ended December 31, 2011, which is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

  99.1 Unaudited pro forma condensed combined statement of operations of the Company and Graceway Pharma Holding Corp. and subsidiaries for the year ended December 31, 2011.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    MEDICIS PHARMACEUTICAL CORPORATION
Date: May 10, 2012     By:   /s/ Seth L. Rodner
      Seth L. Rodner
     

Executive Vice President, Chief Legal Officer and

Corporate Secretary

EXHIBIT INDEX

 

Exhibit No.

   

Description

99.1    Unaudited pro forma condensed combined statement of operations of the Company and Graceway Pharma Holding Corp. and subsidiaries for the year ended December 31, 2011.